baber/WOPTO huggingface dataset:
Patent AU-2007251471-B2 (AU)
Title: New form of administration of racecadotril
Inventor: LECOMTE JEANNE-MARIE
IPC: A61K9/28
Filed: 2007-05-14
Granted: 2012-03-15
Abstract: This invention concerns a new formulation for racecadotril in the form of tablets, including the preparation process and their use for treating diarrhea.
Patent AU-2007266713-B2 (AU)
Title: Dissolvable tobacco film strips and method of making the same
Inventor: WRENN SUSAN E
IPC: A23L27/00
Filed: 2007-05-25
Granted: 2013-05-23
Abstract: A consumable tobacco film strip (200) adapted to dissolve in the oral cavity includes a tobacco component (250), a binder, a humectant, and optionally a flavorant. The tobacco component can include ground or powdered tobacco and/or a tobacco extract. Tobacco flavoring can be incorporated in the film strip by casting or extruding a mixture or the tobacco component may be added to a film strip after formation of the film. The film strips are adapted to dissolve and provide tobacco satisfaction.
Patent AU-2007275316-B2 (AU)
Title: Fatty acid desaturases from Tetraselmis suecica
Inventor: URSIN VIRGINIA
IPC: A23L29/20
Filed: 2007-07-18
Granted: 2012-09-06
Abstract: The invention relates generally to methods and compositions concerning desaturase enzymes that modulate the number and location of double bonds in long chain poly-unsaturated fatty acids (LC-PUFA's). In particular, the invention relates to methods and compositions for improving omega-3 fatty acid profiles in plant products and parts using desaturase enzymes and nucleic acids encoding for such enzymes. In particular embodiments, the desaturase enzymes are Tetraselmis suecica delta 6 desaturases. Also provided are improved soybean oil compositions having GLA and SDA.
Patent AU-2008205373-B2 (AU)
Title: Non-imaging facet based optics
Inventor: DOMENICO LEO DI
IPC: F24S23/00
Filed: 2008-01-08
Granted: 2011-09-15
Abstract: A high efficiency and compact optical device comprising two or more active and resonating optical facet surfaces defined by a three-dimensional representation and configured to provide a three-dimensional device. A focal region, remote from the optical surfaces and non contiguous therewith, is defined by two or more active optical resonant surfaces, at least one of which is self-resonant. The optical surfaces in general do not have a continuous second derivative and are defined by a piecewise continuous surface function providing radially directed facets. The optical device comprises a transparent dielectric body with its optical surfaces being formed on the surfaces of said transparent dielectric body. A light transducer may be located at a focal region to provide an energy conversion. A light source having a physical extension in space, such as an LED, may be located at the focal region to provide collimation. In some embodiments the active surfaces may be chosen to transform incident radiation into a predetermined shape and having a predetermined spatial power distribution.
Patent AU-2008215561-B2 (AU)
Title: Multi-piece rim and its attaching/removing method
Inventor: NAKAMURA YUKIO
IPC: B60B25/04
Filed: 2008-02-08
Granted: 2012-07-05
Abstract: A multi-piece rim which does not need much labor for supporting, and does not increase the number of components to be managed and the number of needed tasks. A lock ring (40) to be fitted in the groove (11a) of a gutter band (11) is divided into a plurality of portions (41, 42), and they are coupled at one end (41a, 42a) of each through a flexible coupling member (43). Alternatively, a lock ring (140) is formed into a substantially C-shape obtained by cutting a part of a circular ring, and is constituted of a first portion (141) where the length of a chord at the cut portion is substantially equal to the diametral dimension of a hub, and a second portion (142) having a shape corresponding to that at the cut portion of a circular ring in the first portion.
Patent AU-2008238298-B2 (AU)
Title: 4-(4-trifluoromethyl-3-thiobenzoyl)pyrazoles, and use thereof as herbicides
Inventor: KEHNE HEINZ
IPC: A01N43/56
Filed: 2008-04-01
Granted: 2012-11-08
Abstract: Disclosed are 4-(4-trifluoromethyl-3-thiobenzoyl)pyrazoles of general formula (I) as well as the use thereof as herbicides. In said formula (I), R, R, R, and R represent radicals such as hydrogen and organic radicals such as alkyl, and Y represents hydrogen or a protective group such as tosyl.
Patent AU-2008249230-B2 (AU)
Title: Fault tolerant led display
Inventor: GUTHRIE DON W
IPC: H01L25/16
Filed: 2008-11-27
Granted: 2011-08-18
Abstract: Zener diodes Z1, Z2 are connected in parallel with sets 201a, 201b of series-connected light emitting diodes L1-L4 with a reverse forward bias orientation. The threshold voltage of the zener diodes Z1, Z2 is matched to equal, or be just slightly greater than, the forward voltage 5 drops for the light emitting diodes LI -L4 at maximum current. During normal operation, therefore, the zener diodes ZI, Z2 draw virtually no current. Upon failure of one of the light emitting diodes Li -L4, the associated zener diode Z or Z2 conducts without increase in the applied voltage, providing an alternate current path maintaining circuit integrity so that other set 20 1a or 201b of light emitting diodes L1-L2 or L3-L4 connected in series within the circuit 200 10 continues to illuminate.
Patent AU-2008254676-B2 (AU)
Title: An improved LED device for wide beam generation and method of making the same
Inventor: RHOADS GREG
IPC: B60Q1/26
Filed: 2008-05-19
Granted: 2012-03-22
Abstract: A predetermined illuminated surface pattern is generated from a predetermined energy distribution pattern of an LED light source within an LED package having a light transmitting dome. An estimated optical transfer function of a lens shape of an optic is defined by the shape of an exterior and inner surface which envelopes at least in part the light transmitting dome of the LED package. An energy distribution pattern is obtained by combination of the estimated optical transfer function and the predetermined energy distribution pattern of the light source. A projection of the energy distribution pattern onto the illuminated surface is determined. The projection is compared to the predetermined illuminated surface pattern. The estimated optical transfer function is then modified and the steps repeated until acceptable consistency is achieved between the projection and the predetermined illuminated surface pattern.
Patent AU-2008261137-B2 (AU)
Title: Antibodies to OPGL
Inventor: CORVALAN JOSE R
IPC: A61K31/519
Filed: 2008-12-19
Granted: 2012-10-04
Abstract: Abstract Antibodies that interact with osteoprotegerin ligand (OPGL) are described. Methods of treating osteopenic disorders by administering a pharmaceutically effective amount of antibodies to OPGL are described. 5 Methods of detecting the amount of OPGL in a sample using antibodies to OPGL are described.
Patent AU-2009206243-B2 (AU)
Title: Methods for determining the risk of prenatal complications
Inventor: CUCKLE HOWARD
IPC: G16H10/60
Filed: 2009-01-26
Granted: 2014-10-02
Abstract: The disclosure relates to methods, medical profiles, kits and apparatus for use in determining the risk that a pregnant individual has for developing pre-eclampsia based on amounts of certain biochemical markers in a biological sample from the individual and biophysical markers. The disclosure also relates to methods, medical profiles, kits and apparatus for use in determining the risk that a pregnant individual is carrying a fetus having a chromosomal abnormality based on amounts of certain biochemical markers in a biological sample from the individual and biophysical markers.
Patent AU-2009214446-B2 (AU)
Title: Method and apparatus to treat well stimulation fluids in-situ
Inventor: SMITH DAVID RANDOLPH
IPC: E21B43/00
Filed: 2009-02-14
Granted: 2012-07-19
Abstract: A method and apparatus for the management of injection and production of well fluids in a subterranean well is described to optimize the use of stimulation fluids to enhance their compatibility with subterranean reservoirs and the surface environment and thereby reducing the damage said fluids induce in subterranean reservoirs and upon flow back to the surface reduce their damage to the environment is described. More specifically, this method is directed to the subterranean treatment of injection fluids.
Patent AU-2009234278-B2 (AU)
Title: Pipette tip handling devices and methods
Inventor: MOTADEL ARTA
IPC: B01L3/02
Filed: 2009-04-11
Granted: 2014-11-13
Abstract: Discussed herein are methods and devices for storing, handling, loading or dispensing of pipette tips. Some embodiments allow repetitive loading of an array of multiple pipette tips that are stored in a nested configuration.
Patent AU-2009235931-B2 (AU)
Title: Treatment of tumors
Inventor: LOIBNER HANS
IPC: A61K38/48
Filed: 2009-04-07
Granted: 2015-07-23
Abstract: The invention relates to the use of a polypeptide having an angiotensin converting enzyme 2 (ACE2) activity for producing a drug for treating tumors.
Patent AU-2009255573-B2 (AU)
Title: Aircraft-based Internet Protocol Subnet in an airborne wireless cellular network
Inventor: LAUER BRYAN A
IPC: H04B7/185
Filed: 2009-03-05
Granted: 2013-12-12
Abstract: The Aircraft IP Subnet System provides wireless communication services to passengers located onboard an aircraft by storing data indicative of individually identified wireless devices that are onboard The Aircraft IP Subnet System assigns an IP address to each Point-to-Point Protocol link connecting the aircraft network to the ground-based network and creates an IP subnet onboard the aircraft The subnet utilizes a plurality of IP addresses for each Point-toPoint link, to enable passenger wireless device to be uniquely identified with their own IP address This is enabled since both Point-to-Point Protocol IPCP endpoints have pre-defined IP address pools and/or topology configured, so each Point-to-Point Protocol endpoint can utilize a greater number of IP addresses than one per link This does not change IPCP or other EVDO protocols/messaging but allows this address to be visible to the ground-based network.
Patent AU-2009270944-B2 (AU)
Title: Geographic and keyword context in embedded applications
Inventor: SAH ADAM
IPC: G06F15/16
Filed: 2009-07-15
Granted: 2013-05-23
Abstract: A computer-implemented method includes generating, using an embedded client application, a keyword context for a container document holding the embedded client application; generating, using the embedded client application, a geographic context associated with a device on which the container document is displayed; submitting the keyword context and the geographic context to a remote server; and displaying an interactive application using information obtained in response to the submission of the keyword context and geographic criteria.
Patent AU-2009289470-B2 (AU)
Title: Combination full-duplex and half-duplex electronic identification tag
Inventor: STEWART ROBERT
IPC: H04Q5/22
Filed: 2009-09-04
Granted: 2015-02-19
Abstract: Transponders are disclosed that are configurable to operate In an HDX mode and/or an FDX-B mode and that use a switchable load impedance across the transponders' resonant antenna circuit to induce amplitude and/or frequency modulation. An RF level detection circuit determines when the instantaneous activation signal strength is sufficient to support monoplex, multiplex, and diplex operation. A non-volatile memory stores identification data coded in HDX and FDX-B formats. One embodiment of the invention includes an inductive antenna including two terminals connected to tag circuitry, where the inductive antenna forms a resonant antenna circuit tuned to resonate at the frequency of the activation signal.
Patent AU-2009297294-B2 (AU)
Title: Novel oxazolidinone derivatives with cyclic amidoxime or cyclic amidrazone and pharmaceutical compositions thereof
Inventor: CHO YOUNG LAG
IPC: C07D403/08
Filed: 2009-09-22
Granted: 2013-10-31
Abstract: Disclosed is a novel oxazolidinone derivative, particularly a novel oxazolidinone compound with a cyclic amidoxime or cyclic amidrazone group. Also disclosed is a pharmaceutical antibiotic composition including a novel oxazolidinone derivative, a prodrug thereof, a hydrate thereof, a solvate thereof, an isomer thereof or a pharmaceutically acceptable salt thereof as an effective ingredient. Because the novel oxazolidinone derivative, a prodrug thereof, a hydrate thereof, a solvate thereof, an isomer thereof or a pharmaceutically acceptable salt thereof exhibits a wide antibacterial spectrum against resistant bacteria, a low toxicity, and a strong antibacterial activity against Gram-positive and Gram-negative bacteria, it can be usefully used as an antibiotic.
Patent AU-2009318435-B2 (AU)
Title: Liquid detergent composition
Inventor: MIYAKE TOSHIO
IPC: C11D3/43
Filed: 2009-11-19
Granted: 2015-01-15
Abstract: Disclosed is a liquid detergent composition which contains (a) a nonionic surfactant which is obtained by adding ethylene oxide and an alkylene oxide having 3-5 carbon atoms to a compound expressed as R-OH (wherein R represents an alkyl group having 8-18 carbon atoms or an alkenyl group) under specific conditions, (b) an anionic surfactant and (c) a water-miscible organic solvent, respectively at specific ratios.
Patent AU-2009325425-B2 (AU)
Title: Method for manufacturing composite substrate on which wide bandgap semiconductor is laminated
Inventor: AKIYAMA SHOJI
IPC: H01L21/02
Filed: 2009-12-10
Granted: 2014-10-02
Abstract: Provided is a method for manufacturing a low-cost bonded wafer (8) which allows bulk crystals of a wide bandgap semiconductor (1) to be transferred onto a handle substrate (3) as thinly as possible without damaging the substrate. The bonded wafer manufacturing method is a method for manufacturing a bonded wafer (8) by forming a wide bandgap semiconductor thin-film layer (4) on the surface of a handle substrate (3), and comprises, in the following order, a step in which ions are implanted from the surface (5) of a wide bandgap semiconductor (1) having a bandgap of 2.8 eV or greater to form an ion-implanted layer (2), a step in which a surface activation treatment is applied at least to the aforementioned surface of the aforementioned handle substrate (3) or the aforementioned ion implantation surface (5) of the aforementioned wide bandgap semiconductor (1), a step in which the aforementioned surface (5) of the aforementioned wide bandgap semiconductor (1) and the surface of the aforementioned handle substrate (3) are bonded to obtain a bonded body (6), a step in which a heat treatment is applied to the aforementioned bonded body (6) at a temperature of 150‑400°C, and a step in which visible light is irradiated toward the ion-implanted layer (2) of the aforementioned wide bandgap semiconductor (1) from the semiconductor substrate (1) side of the aforementioned bonded body (6) to embrittle the interfacial surface of the aforementioned ion-implanted layer (2) and transfer the wide bandgap semiconductor thin-film layer (4) onto the handle substrate (3).
Patent AU-2009331723-B2 (AU)
Title: Method for producing polymeric, ionic imidazolium compounds
Inventor: SIEMER MICHAEL
IPC: C08G73/06
Filed: 2009-12-10
Granted: 2015-04-02
Abstract: The invention relates to a method for producing polymeric, ionic imidazolium compounds, characterized in that - an α-dicarbonyl compound, - an aldehyde, - at least one amino compound having at least two primary amino groups, - optionally an amino compound having only one primary amino group, and - a hydracid are reacted with each other, wherein optionally the carbonyl groups of the α-dicarbonyl compound and of the aldehyde can be present also as hemiacetals, acetals, hemiketals, or ketals.
Patent AU-2009333239-B2 (AU)
Title: Antioxidant-containing food composition for use in inhibiting histamine pathways in companion animals
Inventor: BROCKMAN JEFFREY A
IPC: A61K31/385
Filed: 2009-12-16
Granted: 2012-08-30
Abstract: The invention encompasses methods for inhibiting histamine release pathways in a companion animal, for example, felines and in treating or preventing idiopathic cystitis or interstitial cystitis. The compositions and methods of the invention include an amount of lipoic acid that is effective in inhibiting histamine release pathways in a companion animal, for example, felines and in treating or preventing idiopathic cystitis or interstitial cystitis.
Patent AU-2010200068-B2 (AU)
Title: Portable isolation enclosure
Inventor: ELLEN THOMAS D
IPC: A47C29/00
Filed: 2010-01-08
Granted: 2011-12-22
Abstract: Abstract An isolation enclosure is provided for isolating a person to an area about a bed, wherein the bed is adapted to support the person and includes a frame and a mattress overlying the frame. The isolation enclosure comprises a frame adapted to surround the bed; and a canopy connectable to the frame and defining an isolation chamber sealed with respect to the ambient atmosphere. The isolation chamber extends over the frame of the bed and is sufficiently large to allow a person located within the isolation chamber to be supported on the bed and to move freely within the isolation chamber. The canopy includes a base wall adapted to either (i) overly the mattress of the bed, and (ii) lie between the mattress and the frarne of the bed- A frame transport device, such as wheels, casters, or sliders, is mounted on the frame and adapted to transport the frame and canopy in cooperation with the bed to thereby transport a patient supported on the bed and located within the isolation chamber. An environmental control device is connectable in fluid communication with the isolation chamber and includes (i) a filter adapted to filter air entering and filter air exiting the isolation chamber, and (ii) a pump adapted to pump air into the isolation chamber to increase the pressure within the isolation chamber relative to the ambient atmosphere, and pump air out of the isolation chamber to decrease the pressure within the isolation chamber relative the ambient atmosphere. 2iG0697_1 (GHMters) 108 100-108 104 180 -102 200 206 206
Patent AU-2010200670-B2 (AU)
Title: Low density medical bandage substrate, medical bandage, and medical bandaging product
Inventor: EVANS JOHN
IPC: A61F5/00
Filed: 2010-02-24
Granted: 2012-05-24
Abstract: Abstract: A low density fabric substrate for a medical bandaging product. The substrate has a plurality of longitudinally-extending voids formed in the fabric for permitting water penetration through the fabric thickness from one of the major faces to the other major faces. A reactive system is impregnated into or coated onto the substrate and remains stable when maintained in substantially moisture-free conditions and hardens upon exposure to sufficient moisture to form a rigid, self supporting structure. A soft, flexible protective material covers at least one of the major faces of the substrate along its length to provide a cushioning barrier between the substrate and the skin of a patient when the material is in use. WO 2006/091349 PCT/US2006/003747 (0 co/ Ile ,1i A'fr
Patent AU-2010237344-B2 (AU)
Title: Method of determining density of underground formations using neutron-gamma ray measurements
Inventor: EVANS MICHAEL
IPC: G01V5/10
Filed: 2010-04-14
Granted: 2015-07-16
Abstract: A method of determining the density of an underground formation surrounding a borehole from measurement of gamma rays arising from irradiation of the formation by a nuclear source in a tool body located in the borehole, and measurement of gamma-ray flux in the tool body at two different detector spacings from the source, the method comprising determining a substantially straight-line relationship between gamma-ray flux measurements at each different spacing with respect to the density of the formation for a tool body with no standoff; determining a relationship defining the deviation with respect to tool standoff of the density determined from the measured gamma-ray flux measurements at the two different detector spacings from the density calculated from the straight line relationships; and for a given pair of gamma-ray flux measurements at the different detector spacings, determining the intersection of the relationship defining the deviation with the straight line relationship so as to indicate the density of the formation surrounding the borehole; wherein the source is a neutron source and the gamma rays measured in the too! body are neutron-induced gamma rays resulting from neutron irradiation of the formation.
Patent AU-2010241934-B2 (AU)
Title: System and method for fiducial deployment
Inventor: DUCHARME RICHARD W
IPC: A61M37/00
Filed: 2010-04-21
Granted: 2014-01-16
Abstract: Embodiments include a fiducial deployment system (1000) and method for use thereof. A fiducial (400) may include one or more protuberances (408) configured to engage one or more slots (806) in a needle of the system. The needle (800) may be configured to deliver a plurality of fiducials (400) to a target location in serial fashion, one at a time. In certain embodiments, echogenic placement of fiducials (400) may present certain advantages.
Patent AU-2010247648-B2 (AU)
Title: Low temperature sintering of dye-sensitised solar cells
Inventor: CONNELL ARTHUR
IPC: H01G9/20
Filed: 2010-03-09
Granted: 2014-06-12
Abstract: This invention relates to the field of dye-sensitised solar cells and discloses a method for reducing the temperature necessary for sintering the metal oxide paste coating the electrode.
Patent AU-2010257388-B2 (AU)
Title: Scleral prosthesis for treating presbyopia and other eye disorders and related devices and methods
Inventor: GRIFFIS III JACK C
IPC: A61F2/14
Filed: 2010-12-22
Granted: 2013-01-10
Abstract: In a first aspect, the invention provides a scleral prosthesis that includes a body having a first shape at a first temperature and a second shape at a second temperature, the body having first and second ends that are narrower in the first shape and wider in the second shape, the first and second ends in the second shape being wider than a middle portion of the body in the second shape. In a second aspect, the invention provides a system that includes a scleral prosthesis according to the first aspect and a sheath having a blade configured to cut scleral tissue of a patient's eye to form an incision, wherein the scleral prosthesis is located within the sheath.
Patent AU-2010261496-B2 (AU)
Title: A slush
Inventor: WINSTON SCOTT
IPC: A23G9/34
Filed: 2010-06-15
Granted: 2013-10-24
Abstract: A slush beverage formulation and method for preparing same that, once reaching a steady-state temperature in a freezer, results in a pourable slush. The pourable slush is obtained by formulating to a specific range of ingredient content, dependent on the alcohol content of the end product. In a preferred form, an ice-nucleating agent and/or an ice-particle-shape-controlling ingredient are added.
Patent AU-2010262010-B2 (AU)
Title: Method for the preparation of oil-containing meat-based products comprising a reduced amount of additives
Inventor: DOMAZAKIS EMMANOUIL
IPC: A23L13/60
Filed: 2010-03-29
Granted: 2013-12-05
Abstract: The present invention relates to oil-containing meat-based products, preferably emulsion- type meat-based products, minced or coarsely comminuted meat-based products, pate and fresh (raw) sausages, comprising besides the standard ingredients commonly foreseen for the particular meat-based products a reduced amount of additives selected from emulsifying agents, stabilizing agents and/or thickening agents. Preferably, the oil- containing meat-based products of the present invention contain a maximum of only one single additive selected from emulsifying agents, stabilizing agents and/or thickening agents. More preferably, the meat-based products of the present invention contain no additives, i.e. no emulsifying agents, no stabilizing agents and no thickening agents. Moreover, the present invention pertains to a process for preparing said oil-containing meat-based products.